These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 16202931

  • 1. Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer.
    Downs LS, Lima PH, Bliss RL, Blomquist CH.
    J Soc Gynecol Investig; 2005 Oct; 12(7):539-44. PubMed ID: 16202931
    [Abstract] [Full Text] [Related]

  • 2. Endometrial carcinoma expresses an increased cathepsin B/D ratio.
    Bradley WH, Lima PH, Rodgers L, Blomquist CH, Downs LS.
    Gynecol Oncol; 2008 Jan; 108(1):84-9. PubMed ID: 17980407
    [Abstract] [Full Text] [Related]

  • 3. [Proteolytic lysosomal enzymes in ovarian cancer].
    Kozyreva EA, Zhordaniia KI, Bassalyk LS, Vasil'ev AV.
    Vopr Med Khim; 1991 Jan; 37(4):20-3. PubMed ID: 1750203
    [Abstract] [Full Text] [Related]

  • 4. [Cathepsin D activity in human ovarian carcinoma].
    Reich W, Wagner F, Hofmann KD, Marzotko F, Schmeisser G.
    Zentralbl Gynakol; 1984 Jan; 106(3):196-200. PubMed ID: 6702349
    [Abstract] [Full Text] [Related]

  • 5. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.
    Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A, Suzumori K.
    Gynecol Oncol; 2004 Mar; 92(3):881-6. PubMed ID: 14984956
    [Abstract] [Full Text] [Related]

  • 6. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
    Guzińska-Ustymowicz K, Zalewski B, Kasacka I, Piotrowski Z, Skrzydlewska E.
    Anticancer Res; 2004 Mar; 24(5A):2847-51. PubMed ID: 15517887
    [Abstract] [Full Text] [Related]

  • 7. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.
    Bazzett LB, Watkins CS, Gercel-Taylor C, Taylor DD.
    Gynecol Oncol; 1999 Aug; 74(2):181-7. PubMed ID: 10419729
    [Abstract] [Full Text] [Related]

  • 8. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
    Krepela E, Procházka J, Kárová B, Cermák J, Roubková H.
    Neoplasma; 1997 Aug; 44(4):219-39. PubMed ID: 9473776
    [Abstract] [Full Text] [Related]

  • 9. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
    Talieri M, Papadopoulou S, Scorilas A, Xynopoulos D, Arnogianaki N, Plataniotis G, Yotis J, Agnanti N.
    Cancer Lett; 2004 Mar 08; 205(1):97-106. PubMed ID: 15036666
    [Abstract] [Full Text] [Related]

  • 10. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P, Wu X, Chen W, Liu J, Wang X.
    Gynecol Oncol; 2007 Mar 08; 104(3):714-20. PubMed ID: 17204312
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic significance of determining cathepsin B activity in malignant ovarian tumors].
    Kozyreva EA, Zhordanina KI, Basalyk LS, Vasil'ev AV.
    Vopr Med Khim; 1994 Mar 08; 40(1):25-7. PubMed ID: 8122404
    [Abstract] [Full Text] [Related]

  • 12. [The lysosomal cathepsins B, L and D in development of murine experimental leukemias].
    Khalikova TA, Korolenko TA, Il'nitskaia SI.
    Biomed Khim; 2009 Mar 08; 55(5):621-34. PubMed ID: 20017393
    [Abstract] [Full Text] [Related]

  • 13. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
    Sebzda T, Saleh Y, Gburek J, Warwas M, Andrzejak R, Siewinski M, Rudnicki J.
    J Exp Ther Oncol; 2006 Mar 08; 5(3):223-9. PubMed ID: 16528972
    [Abstract] [Full Text] [Related]

  • 14. [Significance of cathepsin B and D in physiologic and pathologic processes].
    Olszewska D, Drewa T, Makarewicz R, Drewa J, Woźniak A, Maciak R.
    Pol Merkur Lekarski; 2001 Jan 08; 10(55):65-70. PubMed ID: 11320558
    [Abstract] [Full Text] [Related]

  • 15. Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
    Bhattacharya M, Chatterjee SK, Barlow JJ.
    Cancer Res; 1976 Jun 08; 36(6):2096-101. PubMed ID: 57828
    [Abstract] [Full Text] [Related]

  • 16. Type 2 11beta-hydroxysteroid dehydrogenase activity in human ovarian cancer.
    Temkin S, Nacharaju VL, Hellman M, Lee YC, Abulafia O.
    Steroids; 2006 Nov 08; 71(11-12):1019-23. PubMed ID: 17028049
    [Abstract] [Full Text] [Related]

  • 17. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, Zwierz K.
    Hepatogastroenterology; 2008 Nov 08; 55(82-83):388-93. PubMed ID: 18613372
    [Abstract] [Full Text] [Related]

  • 18. Proteinase activity in invasive cancer of the breast. Correlation with tumor progression.
    Benítez-Bribiesca L, Martínez G, Ruíz MT, Gutiérrez-Delgado F, Utrera D.
    Arch Med Res; 1995 Nov 08; 26 Spec No():S163-8. PubMed ID: 8845643
    [Abstract] [Full Text] [Related]

  • 19. Cathepsin B expression in prostate cancer of native Japanese and Japanese-American patients: an immunohistochemical study.
    Sinha AA, Morgan JL, Betre K, Wilson MJ, Le C, Marks LS.
    Anticancer Res; 2008 Nov 08; 28(4B):2271-7. PubMed ID: 18751406
    [Abstract] [Full Text] [Related]

  • 20. Effect of colchicine on the activity of cathepsin B and D in human liver cirrhosis.
    Stancíková M, Frysák Z, Trnavský K.
    Acta Med Hung; 1987 Nov 08; 44(2-3):181-8. PubMed ID: 3684446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.